Plasma von Willebrand factor antigen concentration as a predictor of von Willebrand's disease status in German Wirehaired Pointers

被引:0
作者
Brooks, M [1 ]
Raymond, S [1 ]
Catalfamo, J [1 ]
机构
[1] NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201
关键词
canine species; von Willebrand's disease; von Willebrand factor;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To evaluate the use of plasma von Willebrand's factor (vWF) concentration as a screening test for inherited von Willebrand's disease (vWD) in German Wirehaired Pointers (GWHP). Design-Prospective study. Sample Population-Plasma samples from 467 GWHP. Procedure-Plasma VWF concentrations were measured as vWF antigen (vWF:Ag), using ELISA, and test values were used to estimate prevalence of vWD in GWHP and predict parental vWD status. Test results of progeny from matings of carrier and noncarrier parents were then compared with the predicted outcome of such matings. Results-376 (81%) GWHP were classified as vWD noncarriers, 58 (12%) as carriers, and 5 (1%) as affected with vWD. An additional 28 (6%) GWHP could not be classified on the basis of plasma vWF:Ag concentration. The observed outcome of tests of 213 pups was not significantly different from that predicted on the basis of parental vWF:Ag concentration. The predictive value of a positive test result (VWF: Ag% < 50) for identifying vWD carriers was 0.89. Clinical Implications-Plasma vWF:Ag concentration was an effective predictor of genetic status for the vWD trait, and for the outcome of matings between carriers and noncarriers of vWD in this study of GWHP.
引用
收藏
页码:930 / &
页数:5
相关论文
共 50 条
  • [31] Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations
    Rastegar-Lari, G
    Ajzenberg, N
    Ribba, AS
    Vereycken-Holler, V
    Legendre, P
    Villoutreix, BO
    Meyer, D
    Baruch, D
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1459 - 1465
  • [32] Von Willebrand's disease
    Dietrich, Jennifer E.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2007, 20 (03) : 153 - 155
  • [33] The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma
    Martinez-Vargas, Marina
    Courson, Justin
    Gardea, Luis
    Sen, Mehmet
    Yee, Andrew
    Rumbaut, Rolando
    Cruz, Miguel A.
    BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (05) : 256 - 264
  • [34] The safety of plasma-derived von Willebrand/factor VIII concentrates in the management of inherited von Willebrand disease
    Federici, Augusto B.
    EXPERT OPINION ON DRUG SAFETY, 2009, 8 (02) : 203 - 210
  • [35] Von Willebrand's disease in the German shepherd dog
    Lobetti, RG
    Dippenaar, T
    JOURNAL OF THE SOUTH AFRICAN VETERINARY ASSOCIATION-TYDSKRIF VAN DIE SUID-AFRIKAANSE VETERINERE VERENIGING, 2000, 71 (02): : 118 - 121
  • [36] Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study
    Heijdra, Jessica M.
    Cloesmeijer, Michael E.
    de Jager, Nico C. B.
    Leebeek, Frank W. G.
    Kruip, Marieke H. J. A.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    HAEMOPHILIA, 2022, 28 (05) : 814 - 821
  • [37] Von Willebrand Factor in Health and Disease
    Avdonin, P. P.
    Tsvetaeva, N., V
    Goncharov, N., V
    Rybakova, E. Yu
    Trufanov, S. K.
    Tsitrina, A. A.
    Avdonin, P., V
    BIOCHEMISTRY MOSCOW SUPPLEMENT SERIES A-MEMBRANE AND CELL BIOLOGY, 2021, 15 (03) : 201 - 218
  • [38] Von Willebrand Factor in Health and Disease
    Avdonin, P. P.
    Tsvetaeva, N., V
    Goncharov, N., V
    Rybakova, E. Yu
    Trufanov, S. K.
    Tsitrinal, A. A.
    Avdonin, P., V
    BIOLOGICHESKIE MEMBRANY, 2021, 38 (04): : 237 - 256
  • [39] Study of human von Willebrand factor immunogenicity in pigs with severe von Willebrand disease
    Sauger, A
    Chtourou, S
    Samor, B
    Bonneau, M
    Roussi, J
    Drouet, L
    Mazurier, C
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (03) : 187 - 192
  • [40] Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency
    Chen, CI
    Federici, AB
    Cramer, EM
    Canciani, MT
    Harrison, P
    Zheng, SL
    Massé, JM
    Mannucci, PM
    Hayward, CPM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) : 20 - 28